Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study

ConclusionsOur results suggest that sulfonylureas except for gliclazide increase the CRC risk in type 2 diabetic patients. Long-term follow-up studies are necessary to clarify the association of newer anti-diabetic medications with the CRC incidence.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research